The largest database of trusted experimental protocols

6 protocols using recombinant il 10

1

Cytokine Regulation in Colon Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human colon epithelial cell line CCD841 and human colon carcinoma HT29 and HCT116 cell lines were obtained from American Type Culture (Manassas, VA). HCT116DNMT1−/−, HCT116DNMT3b−/−, and HCT116DNMT1−/− DNMT3b−/− (DKO) were kindly provided by Dr. Bert Vogelstein (Johns Hopkins University, Baltimore, MD). CCD841 and HT29 Cells were treated with recombinant IL10, IL6 or IL22 (Biolegend, San Deigo, CA), or recombinant IFNγ (R&D, Minneapolis, MN) for 2 or 24 h and analyzed by western blotting or/and RT-PCR.
+ Open protocol
+ Expand
2

Optimizing B Cell Activation Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD19 mAb-coated microbeads (Miltenyi Biotec, San Diego, CA) were used to purify splenic B cells by positive selection (> 95% purity) using the manufacturer’s instructions. Purified B cells, whole splenocytes or whole MLNs (1 × 106 cells/ml) were cultured with recombinant IL-4 (50 ng/ml; Biolegend, San Diego, CA) plus LPS (40 μg/ml; Sigma) for 5d. In addition to IL-4 and LPS some cultures contained anti-CD40 (2 μg/ml; eBioscience, San Diego, CA), recombinant IL-10 (50 ng/ml; Biolegend), recombinant IL-21 (100 ng/ml, Biolegend), or anti-IgM (2 μg, Southern Biotech, Birmingham, AL) and 40 μg/ml of anti-IL-10 or IgG1 control (both from Biolegend) for the 5d culture.
+ Open protocol
+ Expand
3

Modulating Intestinal Epithelial Fucosylation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were intraperitoneally injected with 250 μg of purified anti-IL-10 receptor monoclonal antibody (clone 1B1.3A; eBioscience) or purified rat IgG1 as isotype control on every third day 4 times. Two days after the final injection, mice were used for the analysis of epithelial fucosylation.
Mice were intraperitoneally injected with 4 μg of recombinant IL-10 (BioLegend) in 100 μL of PBS or with vehicle alone57 (link)58 (link). Injections were performed on days 0, 2, 4, 6, and 8, and epithelial fucosylation was analyzed on day 10.
+ Open protocol
+ Expand
4

Evaluating IL-17A and BCG Effects on Lung Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A549 cells are an alveolar type-II epithelial cell line, that were cultured in DMEM (Gibco, CA, USA), supplemented with 100 units/mL penicillin, 100 μg/mL streptomycin, and 10 % fetal bovine serum (FBS) (Gibco, CA) at 37 °C, 5 % CO2. Cells were seeded in 96-well tissue culture plates, following 60–70 % adherence. 100 ng/mL recombinant IL-17A (rOPN, R&D, MN, USA) and 15 μg/mL pulmonary Mycobacterium bovis bacille Calmette–Guerin (BCG, Shanghai Institute of Biological Products Co., Ltd, China) were added respectively. Cells and supernatants were harvested at 24 h. The supernatants were used to determine the concentration of lactate dehydrogenase (LDH) according to the manufacturer’s instructions (Roche, Mannheim, Germany). An analysis of cellular apoptosis was carried out according to the manufacturer’s instructions (BD Pharmingen, San Diego, CA, USA).
PBMCs from health volunteers were cultured at 37 °C, 5 % CO2 in RPMI 1640 (Gibco, CA, USA), supplemented with 100 units/mL penicillin, 100 μg/mL streptomycin, and 10 % FBS. Cells were incubated with recombinant IL-10 (10 μg/mL, Biolegend, CA, USA) and BCG (15 μg/mL). Golgi inhibitor was added for the last 5 h of the incubation. Cells were harvested at 24 h, and intracellular cytokine analysis of IL-17A production was conducted according to the manufacturer’s instructions.
+ Open protocol
+ Expand
5

Flow Cytometry Sorting and Analysis of ATL Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
All flow cytometry sorting experiments were performed using a BD FACSAria cell sorter and analyzed by BD FACSDIVA™ software. Patients primary ATL cells, HuT-102 or CEM cell lines were stained with anti CD25-FITC (BD Biosciences, 2 ug/ml; US) before sorting. Sorted cells were analyzed by real-time PCR for Tax and HBZ expression. When indicated, sorted GFP-positive cells were treated with recombinant IL-10 (1 ng/ml) (Biolegend, #571006, US) and cell proliferation was assessed.
Twenty-four hours following transduction of cell lines (HuT-102, MT-1) or primary ATL cells with GFP-lentiviral vectors encoding scrambled (SCR), shRNA Tax or shRNA HBZ, cells were sorted based on GFP expression. The proliferation of GFP+ or GFP cells was assessed using the trypan blue dye exclusion assay. The expression of Tax, HBZ and IL-10 transcripts was assessed by real-time PCR. The expression of Tax protein was assessed by western blot. Cellular localization of RelA (Cell signaling; #D14E12; USA) and PML (homemade, gift from H. de Thé) in these cells was assessed by immunofluorescence assay and confocal microscopy analysis. Finally, protein expression of Dec-1 (Novus biologicals, #NB100-10200; USA), PML (homemade, gift from H.de The), p53 (Santa cruz; #DO-1; Germany), P-p53 (cell signaling #9284; USA) and P-IκBα (Invitrogen, #MA5-15224 US) was assessed by western blot.
+ Open protocol
+ Expand
6

Cytokine Regulation in Colon Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human colon epithelial cell line CCD841 and human colon carcinoma HT29 and HCT116 cell lines were obtained from American Type Culture (Manassas, VA). HCT116DNMT1−/−, HCT116DNMT3b−/−, and HCT116DNMT1−/− DNMT3b−/− (DKO) were kindly provided by Dr. Bert Vogelstein (Johns Hopkins University, Baltimore, MD). CCD841 and HT29 Cells were treated with recombinant IL10, IL6 or IL22 (Biolegend, San Deigo, CA), or recombinant IFNγ (R&D, Minneapolis, MN) for 2 or 24 h and analyzed by western blotting or/and RT-PCR.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!